DIN 02230839 — XYLAC 25 MG
XYLAC is a tablet of Loxapine marketed by PENDOPHARM DIVISION OF PHARMASCIENCE INC. The full Loxapine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02230839
- Brand name
- XYLAC
- Active ingredient
- Loxapine
- Strength
- 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- PENDOPHARM DIVISION OF PHARMASCIENCE INC
- Health Canada status
- MARKETED
- Drug class
- Antipsychotic (first-generation, dibenzoxazepine)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Loxapine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02169991 | LOXAPAC IM | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02230838 | XYLAC | 10 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED |
| 02242868 | XYLAC | 2.5 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED |
| 02230837 | XYLAC | 5 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | DORMANT |
| 02230840 | XYLAC | 50 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | DORMANT |